EFFECTS OF INTERLEUKIN-2 ON CARDIAC-FUNCTION IN THE ISOLATED RAT-HEART

被引:59
作者
SOBOTKA, PA [1 ]
MCMANNIS, J [1 ]
FISHER, RI [1 ]
STEIN, DG [1 ]
THOMAS, JX [1 ]
机构
[1] LOYOLA UNIV,STRITCH SCH MED,DEPT PHYSIOL,MAYWOOD,IL 60153
关键词
cardiac dysfunction; cardiotoxicity; interleukin; 2; lymphokine-activated killer cells;
D O I
10.1172/JCI114783
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Adoptive immunotherapy with IL 2 is associated with severe cardiovascular toxicities including peripheral and pulmonary edema, hypotension decreased systemic vascular resistance, increased heart rate, and an increased cardiac index. The purpose of this investigation was to determine whether IL 2 alone or in combination with lymphokine-activated killer cells (LAK) cells depress cardiac function using the isolated, perfused, working rat heart preparation. Male Sprague-Dawley rats (250-350 g) were anesthetized and the hearts were removed and placed on the perfusion apparatus. Hearts were perfused with oxygenated Krebs-Henseleit buffer (KHB), or oxygenated KHB containing IL 2 alone, IL 2-Media (cell culture media from cultured mononuclear cells from healthy volunteers), or LAK (cell culture media from cultured lymphocytes harvested from patients receiving IL 2/LAK in the presence of 1,500 U/ml IL 2). The cells were removed before perfusion (n = 9). Cardiac output and coronary flow were measured at 20-min intervals with preload constant (afterload varied) or afterload constant (preload varied). The results indicate a significant depression in cardiac function in hearts treated with LAK. This depression was evident at 20 min and was more pronounced at 60 min. Washout of the KHB plus LAK reversed this depression. Thus, IL 2-stimulated/cultured human mononuclear cells produce a soluble factor that produces a reversible severe depression of cardiac function.
引用
收藏
页码:845 / 850
页数:6
相关论文
共 19 条
[1]   EFFECTS OF INTERLEUKIN-2 ON RENAL-FUNCTION IN PATIENTS RECEIVING IMMUNOTHERAPY FOR ADVANCED CANCER [J].
BELLDEGRUN, A ;
WEBB, DE ;
AUSTIN, HA ;
STEINBERG, SM ;
WHITE, DE ;
LINEHAN, WM ;
ROSENBERG, SA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) :817-822
[2]  
COHEN MC, 1988, AM J MED, V85, P549
[3]   REVERSIBLE CARDIAC DYSFUNCTION ASSOCIATED WITH INTERFERON ALFA THERAPY IN AIDS PATIENTS WITH KAPOSIS SARCOMA [J].
DEYTON, LR ;
WALKER, RE ;
KOVACS, JA ;
HERPIN, B ;
PARKER, M ;
MASUR, H ;
FAUCI, AS ;
LANE, HC .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (18) :1246-1249
[4]  
ELLISON MD, 1987, CANCER RES, V47, P5765
[5]  
FAIRMAN RP, 1987, CANCER RES, V47, P3528
[6]   METASTATIC RENAL-CANCER TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - A PHASE-II CLINICAL-TRIAL [J].
FISHER, RI ;
COLTMAN, CA ;
DOROSHOW, JH ;
RAYNER, AA ;
HAWKINS, MJ ;
MIER, JW ;
WIERNIK, P ;
MCMANNIS, JD ;
WEISS, GR ;
MARGOLIN, KA ;
GEMLO, BT ;
HOTH, DF ;
PARKINSON, DR ;
PAIETTA, E .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :518-523
[7]   THE HEMODYNAMIC-EFFECTS OF TREATMENT WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS [J].
GAYNOR, ER ;
VITEK, L ;
STICKLIN, L ;
CREEKMORE, SP ;
FERRARO, ME ;
THOMAS, JX ;
FISHER, SG ;
FISHER, RI .
ANNALS OF INTERNAL MEDICINE, 1988, 109 (12) :953-958
[8]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
GRIMM, EA ;
MAZUMDER, A ;
ZHANG, HZ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841
[9]  
LOTZE MT, 1986, CANCER, V58, P2764, DOI 10.1002/1097-0142(19861215)58:12<2764::AID-CNCR2820581235>3.0.CO
[10]  
2-Z